Press Release | July 21, 2026
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
Read More
Press Release | July 17, 2026
Stanford Board of Trustees elects four new members including Agent Capital advisor Farah Champsi
Read More
Press Release | July 14, 2026
Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington’s Disease to the United States, Canada and the United Kingdom
Read More
Press Release | July 9, 2026
Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints
Read More
